drug · small molecule
latanoprost SR
Phase 2updated 3mo agoby BioLight Israeli Life Sciences Ltd🔗 ChEMBL
Phase 2community read0 votes
🐶 often sniffed alongside
top 8- tagApproval12 co-mentions · 6 sources
- drugXalatan8 co-mentions · 8 sources
- drugLATANOPROST8 co-mentions · 8 sources
- companyEpic Pharma LLC5 co-mentions · 5 sources
- tagAdCom1 co-mentions · 1 sources
- tag510(k) Clearance1 co-mentions · 1 sources
- tagRecall1 co-mentions · 1 sources
- drugCB-03111 co-mentions · 1 sources
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 4 approved and 3 investigational indications.
targets
Prostaglandin F2-alpha receptor
all catalysts(0)
nothing on the calendar yet
Trials studying latanoprost SR
- phase3Reformulated PG324 Ophthalmic Solution for Intraocular Pressure Reduction
- phase3Study of QLS-111-FDC in Open-Angle Glaucoma or Ocular Hypertension
- phase424-hour Effect of Rocklatan Compared With Latanoprost in Open Angle Glaucoma and Ocular Hypertension Patients
- phase4Rocklatan vs Latanoprost Post-DSLT
- phase1Open Label, Sequential-dose Study of PA5108 Latanoprost FA SR Ocular Implant for Mild-moderate Glaucoma
- phase2Next Generation Rocklatan
- phase3MRCT Evaluating NCX 470 vs. Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension
- phase3Phase 3 Trial of NCX 470 vs. Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 8m ago
Found something off?
comments(0)
5-min edit window · permanent after that